Within the group of the recognized Polish experts, based on the data from the PL-ACS Registry, for the first time in the world we confirmed that the upfront combination lipid-lowering therapy is superior to statin monotherapy for all-cause mortality in patients with ACS. These results suggest that in high-risk patients, such an approach, rather than a stepwise therapy approach, should be recommended.

World Heart Federation CVD & Comorbidities and Integrated Care Roadmap Survey
We are pleased to inform you that the World Heart Federation (WHF) is currently working on developing a new Roadmap for Cardiovascular Disease and Comorbidites and Integrated Care. As part of